Management of ovarian cancer has changed-Reference-Cited by-同舟云学术

Management of ovarian cancer has changed

Published:2012-08 Issue:2 Volume:126 Page:313
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Alouini S.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference6 articles.

1. Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer;Barlin;Gynecol Oncol,2012

2. Prognostic significance of mediastinal (18)F-FDG uptake in PET/CT in advanced ovarian cancer;Bats;Eur J Nucl Med Mol Imaging,2012

3. Impact of FDG-PET and -PET/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based approach;Kumar Dhingra;Womens Health,2012

4. Morbidity of diaphragmatic surgery for advanced ovarian cancer: retrospective study of 148 cases;Chéreau;Eur J Surg Oncol,2011

5. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N Engl J Med,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway;International Journal of Molecular Sciences;2020-03-07

2. Altered expression of different GalNAc-transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer;International Journal of Oncology;2017-10-09

3. A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells;Journal of Proteomics;2016-08

4. Inhibition of RUNX2 Transcriptional Activity Blocks the Proliferation, Migration and Invasion of Epithelial Ovarian Carcinoma Cells;PLoS ONE;2013-10-04